Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Ipek Özer"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bradley, John L (AUTHOR), Stillman, Ipek Özer (AUTHOR), Pivneva, Irina (AUTHOR), Guerin, Annie (AUTHOR), Evans, Amber M (AUTHOR), Dana, Reza (AUTHOR)
Publikováno v:
Clinical Ophthalmology. Feb2019, Vol. 13, p225-232. 8p.
Publikováno v:
Journal of cancer research and therapeutics. 18(6)
Breast carcinoma diagnosis can be made with core-needle biopsy (CNB), but there are controversies regarding the evaluation of hormone receptor (HR) status in needle biopsy specimens. When preoperative neoadjuvant therapy is required in breast cancer
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Business & Management Studies: An International Journal. 7:89-97
Technology is one of the main factors of development at the moment when globalization is increasing very fast. The countries that are in competitive for the development and growth have to develop technology by making innovation. The automotive sector
Publikováno v:
Clinical Ophthalmology. 13:225-232
Objectives Dry eye disease (DED) is a complex multifactorial condition of the ocular surface characterized by symptoms of ocular discomfort, irritation, and visual disturbance. Data previously reported from this study showed an increase in prevalence
Publikováno v:
Phoenix Medical Journal.
Publikováno v:
American Journal of Ophthalmology. 182:90-98
Purpose To provide current estimates of the prevalence of diagnosed dry eye disease (DED) and associated demographics among US adults aged ≥18 years. Design Cross-sectional, population-based survey. Methods Data were analyzed from 75 000 participan
Autor:
Ipek Özer Stillman, Bjorn Bolinder, J. Whalen, Dinara Makenbaeva, Apoorva Ambavane, Eugene Felber
Publikováno v:
Journal of Medical Economics. 19:445-461
A cost-effectiveness analysis was performed for sequential treatments of chronic myelogenous leukemia (CML) with tyrosine kinase inhibitors (TKIs) after failure of 1st line imatinib, from a commercial payer perspective in the US.A Markov model was de
Publikováno v:
American journal of ophthalmology. 198
To assess the proportion of comorbidities in patients with dry eye disease (DED) compared with matched patients without DED in a comprehensive US population.Retrospective case-control study.Healthcare records for insurance claims data, detailing medi